Corporate Profile

Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. Our innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA regulated, Class I exempt device for the treatment of hearing loss. Our differentiated, consumer-first solution empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from licensed hearing professionals via phone, text, email or video chat. The Eargo solution is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases

02 Mar '21
New Survey Raises Awareness of Hearing Loss Ahead of World Hearing Day on March 3 SAN JOSE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the results of its
25 Feb '21
Provides Full Year 2021 Financial Guidance Recent Highlights: Net revenues of $22.4 million in the fourth quarter and $69.2 million for the full year of 2020, representing 110.8% and 110.9% increases, respectively, over the corresponding periods of 2019 Gross systems shipped of 12,096 in the fourth
11 Feb '21
SAN JOSE, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will present at the 10 th Annual SVB Leerink Global Healthcare Conference via web cast.